Literature DB >> 22416174

Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search.

Herwig Cerwenka.   

Abstract

Neuroendocrine tumors (NETs) are diagnosed with increasing frequency and patients often present with liver metastases at the time of diagnosis. Apart from treatment of the metastases, resection of the primary tumor at an early phase is recommended to prevent complications, although it may be difficult to locate, especially in patients with functionally inactive NETs. Small and multifocal tumors in the jejunum and ileum represent a particular challenge. Primary hepatic neuroendocrine carcinoma is extremely rare and is diagnosed only after exclusion of other primary tumors. Therefore, some uncertainty may remain, as small non-hepatic primary tumors may escape detection. Diagnostic work-up in these patients includes biochemical assays and imaging modalities (also comprising specific techniques of scintigraphy and positron emission tomography). This editorial highlights the contributions of endoscopy and operative exploration to the search for the primary tumor. Besides esophago-gastro-duodenoscopy, endoscopic ultrasonography, colonoscopy and bronchoscopy, special endoscopic techniques such as balloon enteroscopy or capsule endoscopy are used with growing experience. Compared with balloon enteroscopy, capsule endoscopy is non-invasive and better tolerated, but it cannot localize a lesion precisely and does not allow biopsy or removal of lesions. Before proceeding to surgery, a discussion of the findings by a tumor board should be a standard procedure. Improvements in diagnostic tools have created new perspectives for the detection of obscure primary tumors in patients with neuroendocrine liver metastases, and these searches are best coordinated by a multidisciplinary team.

Entities:  

Keywords:  Endoscopy; Liver metastasis; Neuroendocrine carcinoma; Neuroendocrine tumor; Primary tumor

Mesh:

Year:  2012        PMID: 22416174      PMCID: PMC3296973          DOI: 10.3748/wjg.v18.i10.1009

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

Review 1.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

2.  Capsule endoscopy for the diagnosis of midgut neuroendocrine carcinoma.

Authors:  P Pozzato; M Brancaccio; P Tomassetti; T Casetti; M Ventrucci
Journal:  Dig Liver Dis       Date:  2007-07-26       Impact factor: 4.088

3.  Capsule endoscopy and double balloon enteroscopy for obscure gastrointestinal bleeding: which is better?

Authors:  Bora Keum; Hoon Jai Chun
Journal:  J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 4.029

4.  The yield of wireless capsule endoscopy in the detection of neuroendocrine tumors in comparison with CT enteroclysis.

Authors:  Sarah Johanssen; Mariam Boivin; Herbert Lochs; Winfried Voderholzer
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

5.  Diagnostic evaluation and management of obscure gastrointestinal bleeding: a changing paradigm.

Authors:  Shabana F Pasha; Amy K Hara; Jonathan A Leighton
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

6.  Total enteroscopy with a nonsurgical steerable double-balloon method.

Authors:  H Yamamoto; Y Sekine; Y Sato; T Higashizawa; T Miyata; S Iino; K Ido; K Sugano
Journal:  Gastrointest Endosc       Date:  2001-02       Impact factor: 9.427

7.  The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Authors:  Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 8.  Neuroendocrine carcinoma of unknown primary site.

Authors:  David R Spigel; John D Hainsworth; F Anthony Greco
Journal:  Semin Oncol       Date:  2009-02       Impact factor: 4.929

9.  Survival and prognostic factor analysis in patients with metastatic pancreatic endocrine carcinomas.

Authors:  Jonathan Strosberg; Nancy Gardner; Larry Kvols
Journal:  Pancreas       Date:  2009-04       Impact factor: 3.327

10.  Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors.

Authors:  Tetsuhide Ito; Masao Tanaka; Hironobu Sasano; Yoshiyuki R Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Masayuki Imamura; Ken Kawabe; Kazuhiko Nakamura
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 6.772

View more
  9 in total

1.  Intramedullary spinal cord metastasis from pancreatic neuroendocrine tumor.

Authors:  Jung Ho Kim; Chang Lim Hyun; Sang Hoon Han
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Diagnostic Value of (68)Ga-DOTATATE PET/CT in Liver Metastases of Neuroendocrine Tumours of Unknown Origin.

Authors:  Teik Hin Tan; Boon Nang Lee; Siti Zarina Amir Hassan
Journal:  Nucl Med Mol Imaging       Date:  2013-12-18

Review 3.  Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.

Authors:  Sundeep Malla; Pawan Kumar; Kumble Seetharama Madhusudhan
Journal:  Abdom Radiol (NY)       Date:  2020-09-22

4.  Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings.

Authors:  Basak Gulpinar; Elif Peker; Cigdem Soydal; Mine Araz; Atilla Halil Elhan
Journal:  Br J Radiol       Date:  2020-01-16       Impact factor: 3.039

5.  Giant hepatic carcinoid: a rare tumor with a favorable prognosis.

Authors:  Serge Landen; Maxime Elens; Celine Vrancken; Frederiek Nuytens; Thibault Meert; Veronique Delugeau
Journal:  Case Rep Surg       Date:  2014-02-09

Review 6.  Management of Gastrointestinal Neuroendocrine Tumors.

Authors:  Rongzhi Wang; Rui Zheng-Pywell; H Alexander Chen; James A Bibb; Herbert Chen; J Bart Rose
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-10-24

7.  Childhood neuroendocrine tumors of the digestive system: A single center experience.

Authors:  İbrahim Kartal
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

Review 8.  The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012.

Authors:  Daniela Macedo; Teresa Amaral; Isabel Fernandes; Ana Rita Sousa; Ana Lúcia Costa; Isabel Távora; António Quintela; Paulo Cortes; Luís Costa
Journal:  ISRN Hepatol       Date:  2013-02-14

9.  Liver Metastasis of Gastrointestinal Neuroendocrine Tumors: A Single Center Experience.

Authors:  Bita Geramizadeh; Ali Kashkooe; Seyed Ali Malekhosseini
Journal:  Hepat Mon       Date:  2016-04-30       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.